Perspective treatments for triple-negative breast cancer
dc.contributor.author | Dvořák Josef | cs |
dc.contributor.author | Richter Igor | cs |
dc.contributor.author | Kordíková D. | cs |
dc.contributor.author | Lajbl-Večeřová Katarína | cs |
dc.contributor.author | Hornová Jana | cs |
dc.contributor.author | Rozsypalová Aneta | cs |
dc.contributor.author | Spisarová Eva | cs |
dc.contributor.author | Boublíková Ludmila | cs |
dc.contributor.author | Abrahámová Jitka | cs |
dc.date.accessioned | 2018-09-25T12:18:18Z | |
dc.date.available | 2018-09-25T12:18:18Z | |
dc.date.issued | 2017 | cs |
dc.format.extent | 4 | cs |
dc.identifier.issn | 1802-4475 | cs |
dc.identifier.uri | https://dspace.tul.cz/handle/15240/31792 | |
dc.language.iso | cze | cs |
dc.publisher | Solen | cs |
dc.publisher.city | Olomouc | cs |
dc.relation.ispartofseries | 0 | cs |
dc.subject | triple negative breast carcinoma | cs |
dc.subject | platinum derivates | cs |
dc.subject | olaparib | cs |
dc.subject | bevacizumab | cs |
dc.subject | eribulin | cs |
dc.subject | pembrolizumab. | cs |
dc.title | Perspective treatments for triple-negative breast cancer | en |
dc.title | Perspektivní léčebné postupy u triple negativního karcinomu prsu | cs |
local.citation.epage | 192-195 | cs |
local.citation.spage | 192-195 | cs |
local.identifier.publikace | 5261 | |
local.relation.issue | 11 | cs |